Proteomics Market is Anticipated to Witness High Growth Owing to High Diagnostic Potential

Proteomics Market is Anticipated to Witness High Growth Owing to High Diagnostic Potential

It provides comprehensive information about protein structure, function and modification. Proteomic tools enable evaluation of protein expression levels, interactions, localization and post-translational modifications. Proteomic profiling helps in disease diagnosis by revealing altered protein signatures which can act as biomarkers for various pathological conditions such as cancers, neurological disorders and chronic illnesses.

The global proteomics market is estimated to be valued at US$ 42.4 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the Proteomics Market Size are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, GE Healthcare, Luminex Corporation, PerkinElmer Inc., and Waters Corporation.

Key opportunities in the market include growth in biomarker discovery and diagnostics due to ongoing research in precision medicine and drug development. The increasing availability of large patient datasets and leveraging of artificial intelligence for data analysis promises to revolutionize proteomic profiling and insights.

Globally, North America dominated the proteomics market in 2021 owing to strong government funding for research, rising demand for personalized medicine and presence of key market players in the region. However, Asia Pacific is anticipated to exhibit fastest growth rate over the forecast period driven by rising healthcare expenditure, healthcare reforms and focus on development of technological infrastructure to bolster biomedical sciences.

Market Drivers
High demand for disease diagnostics and drug development is a key growth driver for the proteomics market. Proteomic techniques enable identification of new disease biomarkers and drug targets which facilitates development of accurate diagnostics and precision therapeutics. Moreover, increasing investments by governments and private players in omics research including proteomics will fuel market expansion.

Market Restrains
High costs associated with proteomic instrumentation, reagents and data management pose major challenges especially for smaller healthcare centers and clinical laboratories. Maintaining proteomic data quality and standardization across multi-omics datasets also remains a restraint for widespread commercialization and clinical adoption of proteomic tools. Lack of specialized workforce with integrative omics analytical skills can impede market growth.

Segment Analysis
The proteomics market is dominanted by the protein separation and quantification segment. This segment accounts for over 35% share of the total market owing to increased demand for protein separation and quantification techniques like chromatography and mass spectromerty. These techniques aid in protein identification and quantification which are important initial steps in proteomics research.

The protein identification segment is the second dominating segment. Advancments in mass spectrometry have helped drive growth of this segment. Mass spectrometry based proteomic techniques like matrix assisted laser desorption/ionization (MALDI) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) have enabled high-throughput identification of proteins from complex biological samples.

Global Analysis
North America is the largest and fastest growing regional market for proteomics. High funding for proteomics research from private and public sources and presence of key market players have aided market growth in the region. The region accounts for over 40% of global market share. Availability of advanced research infrastructure along with growing application of proteomics in drug discovery and disease diagnostics are major factors contributing to its dominant position. Asia Pacific is expected to see highest growth during the forecast period owing to increasing R&D investments in biopharmaceutical and life sciences industries in countries like China and India.

Get more insights on This Topic- Proteomics Market

Explore More Articles - India Pallets Market